SCHEMBL13624582

SCHEMBL13624582

Cc1c(C#N)c(=O)[nH]c2c1oc1ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.46
KDM4E B2RXH2 6/20 0.46
LMNA P02545 4/20 0.46
GAA P10253 3/20 0.46
GLA P06280 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.45
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
RXFP1 Q9HBX9 7/20 0.44
PPARG P37231 6/20 0.44
NR2E3 Q9Y5X4 6/20 0.44
NCOR2 Q9Y618 6/20 0.44
NPSR1 Q6W5P4 4/20 0.44
KMT2A Q03164 2/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13624581 0.83 ALDH1A1 (0.46) ALDH1A1KDM4ELMNAGAAGLA
SCHEMBL16814492 0.82 PDE9A (0.60) ALDH1A1KDM4ELMNAGAAGLA
SCHEMBL16814489 0.81 ALDH1A1 (0.63) ALDH1A1KDM4ELMNAGAAGLA
SCHEMBL13624588 0.80 ALPL (0.47) ALDH1A1KDM4EGAAGLAHSD17B10
SCHEMBL13624584 0.79 PDE9A (0.46) KDM4EGAAPDE9AATM
SCHEMBL16814491 0.77 KDM4E (0.52) ALDH1A1KDM4ELMNAGAAGLA
SCHEMBL16814488 0.77 KDM4E (0.52) ALDH1A1KDM4ELMNAGAAGLA
SCHEMBL5323077 0.74 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAGAAGLA
SCHEMBL16814237 0.73 ALDH1A1 (0.67) ALDH1A1KDM4ELMNAGAAGLA
SCHEMBL29206918 0.71 KDM4E (0.57) ALDH1A1KDM4EGAAGLAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622582-B2 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one TIBOTEC BVBA (BE) 2009-11-24 US disclosed
US-7622582-B2 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one TIBOTEC BVBA (BE) 2009-11-24 US disclosed
US-20070213320-A1 4-SUBSTITUTED-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES TIBOTEC BVBA (BE) 2007-09-13 US disclosed
US-20070213320-A1 4-SUBSTITUTED-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES TIBOTEC BVBA (BE) 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213320-A1 4-SUBSTITUTED-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES NR2C2, CYP4B1, OXER1 ALDH1A1 1060/4885KDM4E 3819/4885LMNA 3317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.